Systemic immune suppression in glioblastoma: the interplay between CD14(+)HLA-DR(lo/neg) monocytes, tumor factors, and dexamethasone

Patients with glioblastoma (GBM) exhibit profound systemic immune defects that affect the success of conventional and immune-based treatments. A better understanding of the contribution of the tumor and/or therapy on systemic immune suppression is necessary for improved therapies, to monitor negativ...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Gustafson, Michael P., Lin, Yi, New, Kent C., Bulur, Peggy A., O'Neill, Brian Patrick, Gastineau, Dennis A., Dietz, Allan B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2010
Ämnen:
Basic and Translational Investigations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940665/
https://ncbi.nlm.nih.gov/pubmed/20179016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk